SeikoDianeYamadaMD
Obstetrics & Gynecology • Chicago, ILGynecologic Oncology
Joseph Bolivar DeLee Professor of Obstetrics and Gynecology, University of Chicago Medicine
Dr. Yamada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200
Summary
- I am a board certified gynecologic oncologist and I lead the Section of Gynecologic Oncology at the University of Chicago. I have a keen interest in developing systems to giving the community access to the best gyn oncology care possible. I collaborate with translational and clinical researchers to bring novel therapies to ovarian cancer and endometrial cancer patients. I also have a strong interest in education and administrative leadership. I was a member of the gynecologic oncology board of the American Board of Obstetrics and Gynecology between 2014-2020 and served as President for the Society of Gynecologic Oncology 2021-2022.
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1997 - 1999
Cedars-Sinai Medical CenterFellowship, Gynecologic Oncology, 1995 - 1997
Los Angeles County-Harbor-UCLA Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
David Geffen School of Medicine at UCLAClass of 1991
Brown UniversityBA, Biology and Classics-Latin, 1982 - 1986
Certifications & Licensure
IL State Medical License 1999 - 2026
IN State Medical License 2008 - 2025
CA State Medical License 1993 - 1999- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Deputy Editor Gynecologic Oncology, 2024
- President Society of Gynecologic Oncology, 2021-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
- Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSpatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression.Lisa Schweizer, Rahul Krishnan, Aasa Shimizu, Andreas Metousis, Hilary Kenny
Medrxiv. 2023-11-13 - 7 citationsEndometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study.Rachelle P Mendoza, Peng Wang, Jefree J Schulte, Melissa Y Tjota, Ina Jani
The American Journal of Surgical Pathology. 2023-05-01 - Identity-related experiences of Asian American trainees in gynecologic oncology.Jhalak Dholakia, Yeon Woo Lee, Karen H Lu, Warner K Huh, S Diane Yamada
Gynecologic Oncology Reports. 2022-12-01
Journal Articles
- Case Report Second Primary Rhabdomyosarcoma of the Uterine Cervix Presenting with Synchronous Ovarian Sertoli-Leydig Cell Tumor: An Illustrative Case of DICER1 SyndromeMatthew Cowan, Melody Perpich, Mark A Applebaum, S Diane Yamada, Andrea D Olivas, Ricardo R Lastra, ScienceDirect
Professional Memberships
- Fellow
- Member
- Society of Gynecologic OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
